Status:
COMPLETED
The Effect of a Ankle Assist Robot on Gait Function and Cardiopulmonary Metabolic Efficiency in Stroke Patients
Lead Sponsor:
Samsung Medical Center
Conditions:
Stroke
Gait, Hemiplegic
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
The aim of this study was to identify the assistance effect of Ankle Assist Robot v1 developed by Samsung Advanced Institute of Technology (Samsung Electronics Co, Ltd., Korea) by comparing 1. gait f...
Eligibility Criteria
Inclusion
- Stroke patients with hemiplegia over 19 years old
- Ischemic or hemorrhagic stroke patients over 3 months of onset
- Functional Ambulation Category Scale with 3 or more scales
Exclusion
- Stroke patients who have difficulty in walking independently regardless of assistive devices due to problems such as visual field defects or fractures
- Stroke patients with walking difficulty due to serious cognitive problems
- Patients with a foot size of 230 mm or less or a stroke of 280 mm or more that are not suitable for wearing ankle assist robot
- Stroke patients at risk of falling when walking with severe dizziness
- Modified ashworth scale (MAS) Stroke patients over 3
- Pregnant woman
- People with mental illness and psychiatric medication
Key Trial Info
Start Date :
December 17 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2019
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT03767205
Start Date
December 17 2018
End Date
December 1 2019
Last Update
December 9 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea